Evidence map›Paper›PMID 30002336›Full record

ArticleJournal of functional biomaterials2018

A Decellularized Porcine Xenograft-Derived Bone Scaffold for Clinical Use as a Bone Graft Substitute: A Critical Evaluation of Processing and Structure.

Daniel N Bracey, Thorsten M Seyler, Alexander H Jinnah, Mark O Lively, Jeffrey S Willey, Thomas L Smith, Mark E Van Dyke, Patrick W Whitlock

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. International journal of medical sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Daniel N BraceyDepartment of Orthopaedic Surgery, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. dbracey@wakehealth.edu.ORCID 0000-0001-7159-9186
Thorsten M SeylerDepartment of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC 27710, USA. thorsten.seyler@dm.duke.edu.ORCID 0000-0003-1157-132X
Alexander H JinnahDepartment of Orthopaedic Surgery, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. ajinnah@wakehealth.edu.ORCID 0000-0002-7005-5950
Mark O LivelyDepartment of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. mlively@wakehealth.edu.
Jeffrey S WilleyDepartment of Radiation Oncology, Wake Forest School of Medicine Comprehensive Cancer Center, Winston-Salem, NC 27157, USA. jwilley@wakehealth.edu.
Thomas L SmithDepartment of Orthopaedic Surgery, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. tsmith@wakehealth.edu.
Mark E Van DykeDepartment of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA. mvandyk5@vt.edu.
Patrick W WhitlockDivision of Orthopaedic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. patrick.whitlock@cchmc.org.ORCID 0000-0002-7457-2605
Wake Forest University · USCincinnati Children's Hospital Medical Center · USDuke University · USVirginia Tech · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBone grafts are used in approximately one half of all musculoskeletal surgeries. Autograft bone is the historic gold standard but is limited in supply and its harvest imparts significant morbidity to the patient. Alternative sources of bone graft include allografts, synthetics and, less commonly, xenografts which are taken from animal species. Xenografts are available in unlimited supply from healthy animal donors with controlled biology, avoiding the risk of human disease transmission, and may satisfy current demand for bone graft products.

methodsIn the current study, cancellous bone was harvested from porcine femurs and subjected to a novel decellularization protocol to derive a bone scaffold.

resultsThe scaffold was devoid of donor cellular material on histology and DNA sampling (

conclusionWe are unaware of any porcine-derived bone graft products currently used in orthopaedic surgery practice. Results from the current study suggest that porcine-derived bone scaffolds warrant further consideration to serve as a potential bone graft substitute.

Indexed as

bone graftdecellularizedosteoconductiveporcinescaffoldxenograft

Identifiers

PMID30002336
PMCPMC6164666
OpenAlexW2882344127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.